implants - internationalmagazine of oral implantology

I manufacturer _ news 48 I implants4_2011 Straumann Straumann presents new small-diameter soft tissue-level implant Designedforlimitedinter-dentalspacesornarrow bone ridges, the new Straumann® Standard Plus Narrow Neck CrossFit® (‘NNC’) small diameter soft tissue-level implant offers increased flexibil- ity and additional treatment options, combining the exceptional strength of Straumann’s propri- etary Roxolid® material, the rapid osseointegra- tionoftheSLActive® surfaceandthereliabilityand improved handling advantages of the CrossFit® connection.The NNC implant is in- dicatedforavarietyofuses,includ- ing single-tooth replacement and multiple-tooth replacement with bridges and fixed or removable overdentures. The new implant facili- tates soft-tissue management and can be placed in a one step procedure. Roxolid has been the key to the de- velopmentoftheNNC.Thematerial’s physicalstrengthhasenabledStrau- mann to develop a small diameter implant with an internal rather than an external connection. The design of the implant-abutment interface provides an excellent seal and distributes the bit- ing pressure optimally. It also offers greater flexi- bility for prosthetic angulation. A broad portfolio of surgical and standard pros- theticcomponentsisavailablefortheNNCandwill be complemented by custom abutment options shortly after the full market release. Institut Straumann AG Peter Merian-Weg 12 4052 Basel, Switzerland info@straumann.com www.straumann.com W&H Perfection made simple With Tigon+ W&H has developed a piezo scaler that optimally meets the needs of the patient and dentist. Tigon+hassomeuniquefeatures.Thebestforthe patient: the temperature-controlled fluid. Even sensitive teeth and gums are no longer irritated from now on.Three temperature setting are avail- able for selection. The heating is very easy to set on the display and can also be switched off as re- quired. The five preset pro- grammes(Prophylaxis,Periodon- tology, Endodontics, Restoration and a freely selectable pro- gramme) mean that dentists and dental technicians in particular work more efficient,because they avoid the otherwise necessary manual setting of func- tions for the scaler and machine.The navi-tooth on the display shows which programme is currently in use.Thethreepowermodesallow theusertodefinethescalerpower according to their preferences. Dentists and dental technicians work in the safe knowledge of not treating the tooth too gently or too hard, but working with just the right pressure. The W&H LED technology ensures per- fect lighting conditions and allows the user im- proved visual perception and the same contrast sensitivity as in daylight. The handpiece and LED ringcanbethermallydisinfectedandsterilizedef- fortlessly. Tigon—a piezo scaler that can be oper- ated with ease. The user increases or decreases the power of the scaler by simplypressingtheplusandminus keys and the coolant flow rate at the same time. Other advantages: a stable-standing coolant tank, a generously dimensioned tray and here too,of course,a handpiece with in- novative LED tech- nology ensuring per- fect lighting conditions. The coolant tank has a capacity of 400 ml and is grad- uated in 50 ml steps—so the coolant can be mixed directly in the coolant tank. In addition, the tank stands solidly and stably, even when not attached to the device. It is convenient to set down instruments on the generously equipped tray during treatment. The user can then remove the tray—together with the 360°rotatinghandpiecesupport—fromtheTigon and thermodisinfect and sterilize it. W&H Deutschland GmbH Raiffeisenstraße 4 83410 Laufen, Germany office.de@wh.com www.wh.com Nobel Biocare Nobel Biocare successfully launches a CHF 120 million domestic straight bond issue Nobel Biocare has successfully launched its inau- gural CHF-denominated domestic straight bond is- sue in the aggregate principal amount of CHF 120 million with a coupon of 4%,due 10 October 2016. NobelBiocarewillusethebondproceedstopartially refinance the outstanding convertible bond, which becomes due in November 2011. Nobel Biocare views this bond issue as a particular success given the current,highly volatile market environment. Nobel Biocare Holding AG P.O. Box 8058 Zurich, Switzerland info.switzerland@nobelbiocare.com www.nobelbiocare.com